type species | type | Type (biology) | Diabetes mellitus type 1 | Diabetes mellitus | Type O Negative | Diabetes mellitus type 2 | American Diabetes Association | Volkswagen Type 2 | Type I and type II errors | Type 56 assault rifle | type (biology) | Type 38 | diabetes mellitus | Bugatti Type 57 | Type II supernova | Type Directors Club | Type 38 rifle | type genus | Type 59 | Type 45 destroyer | Jaguar S-Type | Handley Page Type O | Geranylgeranyltransferase type 1 | Blood type | Word (data type) | urban-type settlement | Type species | Type O' Negative | Type 21 frigate |
February 20: Jazz owner Larry H. Miller, who purchased a 50% interest in the Jazz in 1985 and acquired the remaining 50% a year later, dies from complications of type 2 diabetes.
The report highlighted the statistic that 275 Australians were diagnosed with diabetes every day and that by 2025, type 2 diabetes is predicted to triple in prevalence.
Founded in 1953 to support Victorians who are affected by type 1 diabetes, Gestational diabetes, type 2 diabetes and prediabetes, as well as those at risk.
Empagliflozin is drug which is being investigated in clinical trials for the oral treatment of type 2 diabetes by Boehringer Ingelheim and Eli Lilly and Company.
Although ketoacidosis is characteristic of decompensated or untreated type 1 diabetes, ketosis or even ketoacidosis can occur in type 2 diabetes in some circumstances as well.
:Processed foods, high-fructose corn syrup, and increased fat—the greater reliance on processed, packaged, microwaveable food has resulted in a rise in Type 2 Diabetes, obesity, and other health concerns.
An examination of three widely consumed variants have found that its consumption may lower the risk of vascular-related chronic diseases and type 2 diabetes.
Springs was diagnosed with type 2 diabetes in 1990, which led to him having both his right foot and two toes from the left amputated.
A 1997 study concludes that the short-term use of a VLCD is very effective in rapidly improving glycaemic control and promoting substantial weight loss in obese patients with Type 2 diabetes.
In 2007, Wily Mo Peña and his MoPeace Foundation teamed up with Joslin Diabetes Center's Latino Diabetes Initiative for the Beisbol y Salud Latino Diabetes and Health Festival to educate Latino men, women and children about type 2 diabetes.
1980s: C. Ronald Kahn and his team define the molecular mechanism of insulin action and how it is altered in insulin resistant states such as type 2 diabetes and obesity.
1996: A molecular pathway (called NF-κB) is identified in fat and the liver that is activated by obesity (and a fatty diet) and causes the insulin resistance that can lead to type 2 diabetes (Steven E. Shoelson, M.D., Ph.D.).